BioSpace News Archive

Bayer announced today data from the Company’s evolving oncology portfolio will be presented at the 2020 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15, 2020 in San Francisco, California

Topical Roflumilast Cream (ARQ-151) Potential “Best in Class” Topical PDE4 inhibitor Roflumilast Cream Potentially Only Topical PDE4 inhibitor for Psoriasis Open Label Extension Study to Support Potential Recommendations for Long-term Use of Roflumilast Cream  WESTLAKE VILLAGE, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc . (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-med

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2019 financial results.

In a strategic move to better capture opportunities to grow in other states, Mosaic (http://www.mosaicinfo.com), a Nebraska-based provider of personalized services to more than 3,700 people with diverse needs in 10 states, transitioned its Texas services to Caregiver Inc.

Canadians from coast to coast to coast will wear red in observation of Wear Red Canada, a national awareness campaign initiated by the Canadian Women’s Heart Health Alliance to bring attention to women’s cardiovascular health issues.

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it will release financial results for the fourth quarter and full year 2019 after the close of trading on Thursday, February 27, 2020

Ascent Audiology & Hearing has announced the addition of the Lantos 3D Ear Scanning System to select locations in the Greater Washington, D.C., area.

Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k) application for US FDA clearance for its next generation, advanced ECG analysis software.

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has reached an agreement with Clever Claims, LLC to acquire Clever’s 35% stake in Velocity Revenue Cycle, LLC, the joint venture billing and collection company.

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced updated results from the combination arm of KEYNOTE-46 (Part B), the Company’s ongoing Phase 1/2 study investigating ADXS-PSA with KEYTRUDA® (pembrolizumab) in patients with metastatic, castrate-resistant prostate cancer (mCRPC) at the ASCO Genitourinary Cancers Symposium in San Francisco, California.